All that info is in the annual report ref FYE 2016 - Page 81 - for capital structure & page 99 for top 20 shareholders . - available on the asx website & SGH's website .
Back then the top 20 shareholders held some 82 mill shares or approx 23 % of the stock on issue .
Shares on issue at FYE 2016 352,377,933
At 10 cents per share , the current entity has a market cap of only 35 mill approx . IF they can produce some positive numbers - say 10 - 20 mill profit ( even on a before interest & tax basis ) the effect could be enormous as these numbers would be seen as extremely significant when compared with such a low market cap . The share price could bounce wildly as the market re assesses the situation , and has a re think on the business as it might stand now and in the forseeable future .
Not sure how the impact of their friendly cannibalistic financiers will be in that scenario .
I believe u can check with the registry to access the current top 20 shareholders now. This would certainly make for some interesting reading I'm thinking .
No idea about the charts & Lots of IF's and "maybe's" in the above scenario .........
But if it does come together ...u might be able to report some strong break outs from the recent flatline.
cheers
VA
- Forums
- ASX - By Stock
- SGH
- I am back. So is SGH
I am back. So is SGH, page-1730
-
- There are more pages in this discussion • 357 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online